As of 6 Nov 2026, One Global Service Provider trades at 9.7× trailing earnings, below the industry P/E of 27.6×, and the shares are 40% below their 52-week high. Its ROCE of 66% is the highest among its 7 Pharmaceutical Retailers peers. It carries very little debt, and its dividend yield is 0.2%. It is a small-cap company with a market cap of ₹714 Cr, ranked 3rd of 8 Pharmaceutical Retailers companies by market cap; the shares fell 32% over the past year.
- ₹363.35
- ₹380.00
- ₹356.20
- ₹395.75
- 62.3K
Health check
- ReturnsBehind
−32.0% over a year, better than 1 of 7 peers.
- Price tagCheaper
P/E 9.7 vs industry 27.6.
- GrowthStrong
Sales +201.8%, profit +269.3% a year over 3 years.
- ProfitabilityStrong
ROCE 65.7% vs peer median 5.2%.
- Balance sheetFair
Practically debt-free, Piotroski 4 of 9.
- Red flags1 to check
40% below its 52-week high.
Small cap
Defensive
Key metrics
- Market cap
- ₹714 Cr
- Small cap
- P/E
- 9.7
- Industry 27.6
- Price to book
- 5.06
- Peers 2.61
- Dividend yield
- 0.23%
- ROE
- 65.3%
- Peers 8.0%
- ROCE
- 65.7%
- Peers 5.2%
- Debt to equity
- 0.00
- Debt ₹0.03 Cr
- EPS (TTM)
- ₹37.84
- Face value ₹10
- OPM (TTM)
- 19.2%
- Net margin 14.4%
- Sales growth
- +17.0%
- Latest quarter vs a year ago
- Profit growth
- +45.6%
- Latest quarter vs a year ago
- Price to sales
- 1.39
- EV/EBITDA 8.5
Strengths and risks
Strengths
- Return on equity of 65.3%.
- Return on capital employed of 65.7%.
- Practically debt-free.
- Quarterly profit up 45.6% on a year ago.
- Quarterly sales up 17.0% on a year ago.
Risks to check
- 40% below its 52-week high.
About One Global Service Provider
One Global Service Provider Limited engages in the provision of healthcare services worldwide. The company offers diagnostic services, including anemia, antenatal, diabetes, diabetes monitoring, hypertension, kidney, and lipid profiles, as well as liver function tests; and healthcare services, such as end-to-end solutions in industrial occupational check-ups, population screening for non-communicable diseases, disease surveillance programs, electronic…
- Headquarters
- Mumbai
- Employees
- 89
- Sector
- Healthcare
- ISIN
- INE670O01013
- Website
- 1gsp.in
Price range
- Avg volume (3M)
- 22.6K
- 1-year return
- minus 32.0%
- From 52-week high
- minus 39.7%
Peers · Pharmaceutical Retailers
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDPLUSMedplus Health Services | 604.60 | plus 0.66% | 7,260 | 34.3 | 3.47 | 12.2% | 10.8% | 4.2% | 14.7% | 64.0% | 0.00% | minus 25.7% |
| HEALTHXHealth X Platform | 272.55 | minus 0.42% | 867 | – | 1.35 | −0.2% | 0.2% | −4.4% | 8.0% | – | 0.00% | minus 8.3% |
| ONEGLOBALOne Global Service Provider | 365.45 | minus 7.66% | 714 | 9.7 | 5.06 | 65.7% | 65.3% | 19.2% | 201.8% | 269.3% | 0.23% | minus 32.0% |
| TLLTrident Lifeline | 413.75 | minus 2.07% | 495 | 21.0 | 4.22 | 21.8% | 23.6% | 22.8% | 59.7% | 46.8% | 0.24% | plus 40.8% |
| ACHYUTAchyut Healthcare | 7.76 | plus 4.86% | 187 | 776.0 | 5.45 | 1.1% | 1.0% | 2.2% | 62.6% | 10.9% | 0.00% | plus 28.7% |
| MAITRIMaitri Enterprises | 31.20 | plus 0.32% | 14 | 37.6 | 2.61 | 19.9% | 12.1% | 5.4% | 35.8% | – | 0.00% | minus 11.4% |
| MULLERMuller & Phipps (India) | 193.80 | plus 3.11% | 12 | – | −5.82 | 1.8% | – | −17.2% | 12.9% | – | 0.00% | minus 23.9% |
| DPLDipna Pharmachem | 4.31 | plus 1.65% | 11 | 10.5 | 0.18 | 5.2% | 5.2% | 21.2% | 7.7% | 2.2% | 0.00% | minus 78.4% |
| Median of 7 peers | – | 0.66% | 187 | 34.3 | 2.61 | 5.2% | 8.0% | 4.2% | 14.7% | 28.9% | 0.00% | −11.4% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 87.8 | 135 | 141 | 134 | 103 | |
| 74.6 | 109 | 112 | 110 | 83.6 | |
| 13.2 | 26.1 | 29 | 24.3 | 19.2 | |
| 15.1% | 19.3% | 20.5% | 18.1% | 18.7% | |
| 0 | 0.5 | 0 | 0.4 | −0 | |
| 0.2 | 0.2 | 0.1 | 0.3 | 0.1 | |
| 13.1 | 26.4 | 28.9 | 24.3 | 19.1 | |
| 25.0% | 25.0% | 25.1% | 25.3% | 25.0% | |
| 9.8 | 19.8 | 21.7 | 18.2 | 14.3 | |
| 5.02 | 10.13 | 11.08 | 9.31 | 7.32 |
Profit & loss
- Sales CAGR 3Y
- +201.8%
- Profit CAGR 3Y
- +269.3%
- EPS CAGR 3Y
- +163.6%
- ROE
- 65.3%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 18.1 | 63 | 147 | 498 | |
| – | +247.8% | +133.4% | +238.8% | |
| 16.5 | 53.3 | 122 | 405 | |
| 1.7 | 9.7 | 24.8 | 92.9 | |
| 9.1% | 15.4% | 16.9% | 18.6% | |
| −0 | 0 | 0.8 | 0.6 | |
| 0 | – | 0 | 0 | |
| 0.3 | 0.2 | 1.2 | 0.7 | |
| – | – | 0.3 | 0.1 | |
| 1.4 | 9.5 | 24.8 | 92.8 | |
| −1.7% | 25.2% | 25.5% | 25.1% | |
| 1.4 | 7.1 | 18.5 | 69.5 | |
| – | +415.4% | +159.8% | +276.4% | |
| 1.94 | 10.01 | 9.45 | 35.56 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 7.1 | 7.1 | 19.5 | 19.5 | |
| 0.2 | 7.3 | 52.2 | 122 | |
| 0.3 | 0.3 | 0.3 | 0 | |
| 5.2 | 17.1 | 34.3 | 113 | |
| 12.8 | 31.8 | 106 | 254 | |
| 3.7 | 3.5 | 2.6 | 2.2 | |
| 2.8 | 2.8 | 0.2 | 0.4 | |
| 0 | 1.2 | 27.1 | 15.7 | |
| 6.3 | 24.3 | 76.3 | 236 | |
| 12.8 | 31.8 | 106 | 254 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.1 | 1.2 | 14.4 | −10.9 | |
| −0.2 | −0 | −0.1 | −0.2 | |
| – | – | −0.7 | −0.3 | |
| −0 | 1.2 | 13.6 | −11.4 | |
| −0.2 | −0 | −0.1 | −0 | |
| −0 | 1.2 | 14.3 | −11 | |
| – | – | −0.7 | – |
Shareholding pattern
NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 4.4% (Yahoo estimate).
Major shareholders
Filings & events
News
No recent news coverage found.